Tebo Biological (688278.SH) released its performance in the first half of the year, with a net profit attributable to the parent company of 428 million yuan, an increase of 40.60%.

The Zhitong Finance APP news reported that Tebao Biological (688278.SH) released its semi-annual report for 2025, with the company's operating income of 1.511 billion yuan, a year-on-year increase of 26.96%. The net profit attributable to shareholders of the listed company was 428 million yuan, a year-on-year increase of 40.60%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 431 million yuan, a year-on-year increase of 30.68%. The basic earnings per share was 1.05 yuan.